World

CLINICAL USE OF COLORECTAL CANCER VACCINE BEGINS

Russia - medicine

11/18/2026

20:30

CLINICAL USE OF COLORECTAL CANCER VACCINE BEGINS
Photo: SRNA

MOSCOW, NOVEMBER 18 /SRNA/ - Russia has begun clinical use of the Oncopept vaccine to treat colorectal cancer, Igor Borisevich, deputy head of the Federal Medical-Biological Agency /FMBA/, said on Wednesday.


"A vaccine based on neoantigens from an individual patient's cancer cells has been developed, registered and has entered clinical use," Borisevich told a congress session titled "Innovative Practice: Science Plus Business", RIA Novosti reported.

Borisevich added that patients were currently being recruited for the treatment.

The Oncopept peptide vaccine was first given to patients in March.

It is intended for adults who have had surgery and received at least two lines of systemic chemotherapy.

After several months of monitoring the vaccinated patients, FMBA head Veronika Skvortsova said they had not experienced any serious side effects and that the drug was producing the necessary immune response.